3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
8
Melanoma
6
Neoplasm Metastasis
5
Thyroid Neoplasms
4
Thyroid Cancer, Papillary
4
Leukemia, Hairy Cell
4
Carcinoma, Non-Small-Cell Lung
4
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Thyroid Carcinoma, Anaplastic
2
Skin Neoplasms
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Hematologic Neoplasms
2
Glioma
2
Colorectal Neoplasms
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Thyroid cancer, follicular
1
Skin Diseases
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Recurrence
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Noonan syndrome 3
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Interventions
Fulvestrant
5
serabelisib
2
sapanisertib
2
ribociclib
2
palbociclib
2
Paclitaxel
2
Letrozole
2
Irinotecan
2
Gemcitabine
2
Carboplatin
2
Alpelisib
2
venetoclax
1
tivozanib
1
tipifarnib
1
sotorasib
1
pembrolizumab
1
olaparib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
ceralasertib
1
cemiplimab
1
capivasertib
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
Vemurafenib
×
1 year
×
Clear all
No trials found.